Analogous results were obtained with the CDK12 inhibitor, THZ531 which, in line with the effects observed in CDK12-OE MCF10A cells, inhibited PSAT1 and MTHFD1 expression in CDK12HIGH breast cancer cells both at the mRNA and protein level (Supplementary Fig. 6e). This evidence concerns the gene CDK12 and breast cancer.